• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIAO Wen,HOU Wenjing,WEN Aiping.Data mining and analysis of adverse events signals for Montelukast Sodium in children based on FAERS database[J].Journal Of Pharmaceutical Research,2025,44(3):307-312[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2355times   Download 790次 QR Code for this article
Scan with your phone!
基于FAERS数据库的孟鲁司特钠致儿童不良事件信号挖掘与分析
廖雯,侯文婧,温爱萍
Font:Larger+|Default|Smaller-
(首都医科大学附属北京友谊医院药剂科,北京 100050)
摘要:
目的 基于美国食品药品监督管理局不良事件报告系统(FAERS)数据库挖掘孟鲁司特钠上市后致儿童安全警戒信号,为临床安全用药提供参考。方法 运用比例失衡分析法,包括报告比值比法、比例报告比值法,对FAERS数据库收录的从2004年第一季度至2023年第一季度期间,涉及孟鲁司特钠引发的儿童不良事件信号进行筛查与分析。结果 总计搜集到与孟鲁司特钠相关的病例报告12 148份,其中发现226例阳性反应。这些阳性反应分布在18个不同的系统与器官类别中,按发生频次排序,孟鲁司特钠发生频次最多的不良信号分别是攻击、焦虑、异常行为、抑郁、自杀想法,均可见于其药品说明书。按信号强度排序,孟鲁司特钠诱发的视物变形以及导致的米费综合征均未被其药品说明书提及。结论 医务人员应高度关注孟鲁司特钠可能引发的神经系统与精神系统不良事件,特别是在对儿童及有相关病史的患者进行治疗时,并且留意说明书未提及的不良反应。
关键词:  孟鲁司特钠  儿童  FAERS数据库  信号挖掘
DOI:10.13506/j.cnki.jpr.2025.03.016
基金项目:
Publication Date:March 25, 2025
Data mining and analysis of adverse events signals for Montelukast Sodium in children based on FAERS database
LIAO Wen,HOU Wenjing,WEN Aiping
(Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University,Beijing 100050, China)
Abstract:
Objective To analyze post-marketing adverse event reported for Montelukast Sodium in children based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), and provide references for the safe clinical using of the drug. Methods Disproportion analysis techniques, including the reporting odds ratio and proportional reporting ratio, were used to screen and analyze the signals of adverse events in children involving Montelukast Sodium from the FAERS database between the first quarter of 2004 and the first quarter of 2023. Results A total of 12 148 case reports related to Montelukast Sodium were collected, of which 226 were found to be positive. These positive reactions were distributed in 18 different system and organ categories.According to the frequency of occurrence, the most frequent adverse signals of Montelukast Sodium are aggression, anxiety, abnormal behavior, depression, and suicidal thoughts, which can be seen in the drug label. In order of signal intensity, Montelukast induced visual deformations and the resulting Milfie syndrome were not mentioned in the drug label. Conclusion Health care professionals should be extremely concerned about the possible neurological and psychiatric adverse events of Montelukast Sodium, especially when treating children and patients with related medical histories. And they should pay attention to adverse reactions not mentioned in the instructions.
Key words:  Montelukast Sodium  Children  FAERS database  Signal mining
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.